NIH-funded research NIH-funded research

Genomics Shared Resource leadership at a cancer center

Official title: Director Genomics Shared Resource

Funded at Roswell Park Cancer Institute Corp · NIH-11381235 · Data updated 2026-11-12

A cancer center genomics team lead is seeking support to keep a centralized genomics facility running for researchers and clinicians.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRoswell Park Cancer Institute Corp
NIH-funded
Lab location1 site (Buffalo, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2029
Funding year2026
Award (this year)$236,003
NIH project number5R50CA283805-03
Project IDNIH-11381235 on NIH RePORTER

Who could benefit from this research

Could help

Patients with cancer whose tumor genomics might guide diagnosis, prognosis, or treatment decisions could benefit indirectly through faster translation of genomic insights.

Less likely to help

Patients not involved in genomics-guided care or without access to genomic-informed treatment may see no direct benefit.

What this research studies

This grant funds the director of a Genomics Shared Resource (GSR) at a major cancer center. The GSR provides assay design, sample prep, quality control, data generation and analysis to support basic, translational, clinical and population studies. The goal is to accelerate discovery and improve diagnostic and therapeutic decision-making through genomics. It enables collaboration, peer-reviewed funding, and recruitment efforts by offering expert genomic services to researchers and clinicians. The focus is on personalized cancer research and integrating genomics into patient care.

Why it matters

Potential benefit: Patients could benefit indirectly through faster development of personalized cancer therapies and better genomic-informed clinical decisions.

How similar studies have gone: Genomics cores and shared resources have historically shown value by enabling high-quality data generation and accelerating discoveries in cancer.

Where this research is happening

  • Roswell Park Cancer Institute Corp
    Buffalo, United States
    Active

Researchers

  • Principal investigator: Singh, Prashant Kumar — Roswell Park Cancer Institute Corp
  • Study coordinator: Singh, Prashant Kumar

Related research

Other NIH-funded projects on the same topics.

  • A network for sharing data and resources in immuno-oncology.

    This study is all about bringing together experts to find better ways to treat cancer by understanding why some treatments don’t work and discovering new targets for the immune system, which could lead to more personalized and effective therapies for adults.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-9889667

  • A network for sharing data and resources in immuno-oncology

    This study is all about finding better ways to treat cancer using the body's immune system by working together with different experts to share information, which could lead to new treatments and help patients like you have more effective options.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-9625289

  • Targeting retrotransposons to help kids with hard-to-treat cancers like neuroblastoma

    Aims to repurpose safe antiviral drugs to block retrotransposons in children with relapsed or refractory neuroblastoma to improve outcomes.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-11535292

  • MedSupport: Helping families overcome barriers to kids' chemotherapy medicines

    This program offers extra support to parents of children with acute lymphoblastic leukemia to help them give home chemotherapy medicines more reliably.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-11508243

  • Innate immune cells and female lung cancer risk

    A study exploring how certain immune cells in the lungs may contribute to lung cancer in young women who don’t smoke.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-11455512

  • Effect of ONP filler materials on how fast nicotine is delivered

    This grant tests how different filler materials in oral nicotine pouches affect how quickly nicotine is released and absorbed in the mouth.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-11455485

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.